MAGGIORA, Piera
 Distribuzione geografica
Continente #
NA - Nord America 244
EU - Europa 131
AS - Asia 77
AF - Africa 1
Totale 453
Nazione #
US - Stati Uniti d'America 240
CN - Cina 37
UA - Ucraina 24
SE - Svezia 23
SG - Singapore 23
DE - Germania 19
IE - Irlanda 15
FI - Finlandia 12
FR - Francia 12
KR - Corea 12
GB - Regno Unito 10
IT - Italia 7
PL - Polonia 4
CA - Canada 3
NL - Olanda 2
RU - Federazione Russa 2
IN - India 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
SN - Senegal 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 453
Città #
Santa Clara 39
Chandler 28
Beijing 25
Singapore 18
Dublin 15
Woodbridge 14
Ann Arbor 11
Ashburn 11
Dearborn 11
Houston 11
Jacksonville 11
Villeurbanne 9
Medford 7
Princeton 6
Falls Church 5
Boardman 4
Columbus 4
Menlo Park 4
Warsaw 4
Wilmington 4
Düsseldorf 3
Milan 3
Nyköping 3
Boston 2
Guangzhou 2
Hefei 2
Toronto 2
Verona 2
Washington 2
Almaty 1
Cambridge 1
Dong Ket 1
Dushanbe 1
Fuzhou 1
Jinan 1
Lachine 1
Leawood 1
Munich 1
Nanchang 1
Nanjing 1
Norwalk 1
Philadelphia 1
Pune 1
Riga 1
Taiyuan 1
Torino 1
Turin 1
Xi'an 1
Yantai 1
Totale 282
Nome #
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression 97
Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitro 82
erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents. 79
Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms. 79
The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. 75
Feline stk gene expression in cat mammary carcinomas 54
Totale 466
Categoria #
all - tutte 1.656
article - articoli 0
book - libri 0
conference - conferenze 210
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 18 8 2 6 5 2 0
2020/202141 4 0 6 3 5 2 3 1 9 3 2 3
2021/202251 1 1 3 3 3 4 3 2 2 3 12 14
2022/202377 11 2 2 4 14 14 8 4 13 0 4 1
2023/202432 3 5 3 2 4 11 0 0 0 0 1 3
2024/202581 0 10 2 5 40 24 0 0 0 0 0 0
Totale 466